Partners

 

1. FORTH - Foundation for Research and Technology Hellas

 

Greece

Greece - EL

FORTH

Institute of Molecular Biology & Biotechnology (IMBB)

The Institute of Molecular Biology and Biotechnology (IMBB), is one of the 7 Institutes of the Foundation for Research and Technology (FORTH) and the most prominent research institution in Greece, with an outstanding track record of excellence. IMBB is located outside the city of Heraklion, on the island of Crete, an EU convergence region. Over the past 25 years, the IMBB and FORTH have gained extensive visibility as a success story in European research representing remarkable proof of how an agricultural region in the EU periphery can indeed converge and be transformed into a primary producer of knowledge and of leading-edge technology through constant support from EU competitive funds.

 

2. LMU München - Ludwig-Maximilians-Universität München

 

Germany

Germany - DE

LMU

Adolf-Butenandt Institute

The LMU is one of the leading, research-intensive universities in Europe (member of LERU). The LMU is currently building a 125 Mio € ‘Biomedical Center (BMC), to accommodate eight Biomedical Departments, including the ‘Molecular biology Department headed by P.Becker, in 2014. In 2013 the LMU will found a new organizational structure for the Departments that move to the Biomedical Center, BMC) to harbour the, outstanding biomedical research of the preclinical medicine. The Molecular Biology Unit headed by Peter Becker will be part of the BMC, and moving into the new premises in 2014. All groups will have access to start-of-the art core facilities in relevant areas.

 

3. IIT - Fondazione Istituto Italiano di Tecnologia

 

Italy

Italy - IT

IIT

Center for Genomic Science

Bruno Amati is Coordinator of the Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), at the IFOM-IEO Campus. IIT was created with the objective of promoting Italy's technological development and higher education in science and technology. IIT is making an effort to implement its scientific program in this context, with the specific goal of integration between basic scientific research and the development of technical applications. The research is carried out in highly innovative scientific fields, which represent the most advanced frontiers in modern technology; their contents are widely applicable in multiple areas, from medicine to industry, from computer science to robotics, to life sciences and nanobiotechnology. IIT research is carried out according to a Scientific Plan that lasts 3 years. The first Strategic Plan (2005-2008) was dedicated to the construction of the central research laboratory and of the humanoid technology program based on 3 technology platforms (Robotics; Neuroscience; Drug Discovery). The second Strategic Plan (2009-2011) has consolidated the research program with the activation of 4 new technology platforms (Energy; Environment, Health & Safety; Smart Materials; Computation) and with the launch of the national network of IIT laboratories.

 

4. UEDIN - The University of Edinburgh

 

UK

United Kingdom – UK

university of edinburgh

MRC Human Genetics Unit, IGMM

The Medical Research Council Human Genetics Unit is at the forefront of research into human genetics. Its role is to advance the understanding of genetic factors implicated in human disease and normal and abnormal development and physiology. The Unit's programmes of work cover the themes of developmental genetics, common disease genetics, chromosome biology and models for human genetic diseases. The unit is one of the largest MRC research establishments supporting approximately 220 scientists, support staff, fellows, PhD students and visiting scientists.

 

5. IDIBELL - Fundació Institut d'Investigació Biomèdica de Bellvitge

 

Spain

Spain – ES

idibell

Cancer Epigenetic and Biology Program

The Bellvitge Institute for Biomedical Research (IDIBELL) takes a comprehensive approach to cancer and covers the prevention, thoughtful patient care, as well as cutting-edge research. Launched in 2007, the PEBC is IDIBELL’s latest research program. Dr Manel Esteller has set up a centre of excellence in the field of cancer epigenetics at Hospital Duran y Reynals.

 

6. KI - Karolinska Institutet

 

Sweden

Sweden – SE

karolinska institutet

Microbiology, Tumor & Cell Biology

KI has about 3700 employees (full-time equivalents), nearly two-thirds of whom are female. Some 80 per cent of KI’s income is devoted to research, distributed among some 600 research groups covering all medical fields. KI provides excellent postgraduate training with 2100 registered PhD students from around the world are active in both basic and clinical research. Research at KI has a strong European dimension, with almost 200 project participations within the EU’s now closed Sixth Framework Programme (FP6). Of these, KI is coordinating 28 projects. KI is a major player in FP7, participating in about 120 projects including 17 as coordinator as well as ten European Research Council Grants. KI is also the major Swedish beneficiary of funds from the NIH.

 

7. WEIZMANN - Weizmann Institute of Science

 

Israel

Israel – IL

weizman

Computer Science & Applied Mathematics

The Weizmann Institute is devoted to wide-ranging multidisciplinary exploration of the natural, exact and life sciences. There are 2,500 scientists, students, and supporting staff at the institute. The research efforts include research on strategies for protecting the environment, new energy resources, the search for new ways of fighting disease, examining new and outstanding questions in mathematics and computer science, probing the nature of matter and the universe, creating novel materials and in general, enriching human knowledge. Of most relevance to this proposal, Weizmann is widely recognized as an international leader in the area of systems and computational biology, due to several of its scientists that are leaders in the field (e.g., Dr. Uri Alon, Dr. Naama Barkai, Dr. Eytan Domany, Dr. Yitzhak Pilpel, and Dr. Ehud Shapiro). The environment is highly collaborative, and many scientific interactions exist amongst these groups and between my group and these and other experimental groups. These interactions include various types of weekly seminars, collaborative research projects, and jointly advised students. The institute has indicated that it intends to further and significantly grow in the area of systems biology and hire several additional faculty.

 

8. DIAGENODE – DIAGENODE SA

 

Belgium

Belgium - BE

diagenode

Diagenode is a leading developer and marketer of innovative life-science kits, reagents and integrated systems for epigenetics, genomics and diagnostics. Founded in 2003 in Liège (Belgium), Diagenode is a global company, with headquarters in Liège, Belgium and Denville, NJ, USA. Diagenode has a local sales office in United Kingdom. Diagenode currently employs 50 people, including around 8 PhD’s. Diagenode’s customers and partners include leading epigenetics researchers, academic institutions, high-profile genome centres and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Our products provide researchers with the best quality and performance and allow scientists to produce consistent, cost-effective and robust results in their research.

 

9. UD-GENOMED Medical Genomic Technologies

 

Hungary

Hungary – HU

ud-genomed

UD-GenoMed is an innovative R&D company and service laboratory offering large scale clinical genomics studies, molecular testing and related consulting and training services to academia and industry. UD-GenoMed's services are based on the unique know-how of the University of Debrecen. The company's services include complex clinical genomic services with: 1. patient recruitment and biobanking, 2. epigenetic and epigenomic services, functional genomic services, recombinant protein manufacturing and 3. education and training. The company possesses several pieces of know-how in the fields of clinical study coordination, sample collection, biobanking and expression data interpretation and clinical and molecular data integration.

 

10. MOSAIQUES - Mosaiques Diagnostics GmbH

 

Germany

Germany - DE

mosaiques

Mosaiques Diagnostics GmbH has developed and is the leading specialist in clinical proteome and CE-MS analysis, currently the best technology available for identifying disease-specific polypeptide biomarkers in body fluids. MOS has published over 120 papers in peer-reviewed journals on its proprietary technology with more than 4,500 citations and filed over 100 patent applications, further underlining the leading role of this European SME. MOS has developed proprietary hardware for analysis and software solutions for data evaluation, and owns a unique and proprietary database of peptides in human body fluids of currently >20,000 samples (containing >100,000 different peptides and proteins) and their relevance in different age-associated diseases. MOS has ample experience in clinical studies, and is engaged in collaborative projects with regulatory agencies. In addition, MOS has filed for qualification of multiparametric proteomics-based classifiers as BMs for human disease with the relevant regulatory agencies (EMA and FDA).

 

11. ACS - AvantiCell Science Ltd.

 

UK

United Kingdom - UK

avanticell

AvantiCell Science Ltd (ACS) is an SME specialising in cell-based analysis using human primary and stem cells. The company was founded in 2006 and has secured venture capital investment matched by the Scottish Co-Investment Fund, an agency of Scottish Government. AvantiCell has grown organically, through re-investment of profit from commercial business. The company will in April 2014 employ 20 staff in premises located in Ayr, Scotland. ACS is a profitable company, with its commercial business delivering both cell-based services and cell products into the cell-based analysis market, which spans industry sectors, from pharmaceutical drug discovery through nutraceutical and food development, to nanosafety testing. ACS conducts international business in part through JV or subsidiary companies located in SE Asia.

 


 

Associated Partners

 

1. EXIQON – Exiqon A/S

 

Denmark

Denmark - DK

exiqon

Exiqon operates in two business areas, Life Sciences and Diagnostics, which share:

 

2. LIFEGLIMMER – LifeGlimmer GmbH

 

Germany

Germany - DE

lifeglimmer

LifeGlimmer is a start up founded in 2012 with the goal of providing to the Biotechnological, Biomedical and Environmental Research Communities an efficient way to outsource Scientific Computing needs. LifeGlimmer offers a web platform where research groups can set ‘virtual labs’ that function as (1) a data repository, mining and integration, (2) a uniform access point to public data repositories, and (3) an integrated collection of computational tools. The utilization of the platform brings the benefits of a professionally managed IT infrastructure, with state-of-the-art and customized components, without the overhead and the focus-shift associated with in-house solutions. The IT platform is being used in several genome-scale metabolic reconstruction projects in four continents and it has been recently expanded to support metagenomic studies relevant to infection processes.

 

3. YR - Yellow Research

 

netherlands

Netherlands – NL

yellow-research

YR is a Dutch consultancy & training company geared to advising universities with regard to the third money flow, of which advising about research grants strategies is an important part of the work we do. Currently this is dominated by the growing importance of attracting funding through the European Research Council for frontier research. This work brings us in contact with top universities across Europe. Beside preparing researchers in thinking about high-gain/high-risk research, we are involved in the discussions with representatives of university management in the development of strategies to focus research staff on excellent research as well as strategies with regard to tenure tracks. Yellow Research is owned by: Lotte Jaspers, Jet van Dijk, Mette Skraastad.

 

4. SB Science Management

 

Germany

Germany - DE

sb-sciencemanagement

SB ScienceManagement UG i.G. (SBSM) specialises on project management and consulting for third party funding to researchers, institutions and industrial partners from all scientific areas. SBSM is a start up company founded in 2014. The team of SBSM provide long-term experience in science management and bridging the gap between scientific communities and stakeholders. Comprehensive dissemination activities are an integral part of our project management activities.